4//SEC Filing
Elsbree David B 4
Accession 0000950170-23-052936
CIK 0001492674other
Filed
Oct 10, 8:00 PM ET
Accepted
Oct 11, 5:00 PM ET
Size
7.6 KB
Accession
0000950170-23-052936
Insider Transaction Report
Form 4
Elsbree David B
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2023-09-15−2,300→ 0 total→ Common Stock (2,300 underlying) - Exercise/Conversion
Common Stock
2023-09-15+2,300→ 7,824 total
Holdings
- 200(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The reporting person disclaims ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
- [F3]On October 11, 2022, the reporting person was granted 2,300 restricted stock units that vested on the earlier of (i) October 11, 2023, and (ii) the date of the next annual meeting of stockholders.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001292650
Filing Metadata
- Form type
- 4
- Filed
- Oct 10, 8:00 PM ET
- Accepted
- Oct 11, 5:00 PM ET
- Size
- 7.6 KB